Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Otrishko, I. A."'
Publikováno v:
Clinical pharmacy; Vol. 24 No. 4 (2020); 4-14
Клиническая фармация; Том 24 № 4 (2020); 4-14
Клінічна фармація; Том 24 № 4 (2020); 4-14
Клінічна фармація; Том 24, № 4 (2020); 4-14
Clinical pharmacy; Том 24, № 4 (2020); 4-14
Клиническая фармация; Том 24, № 4 (2020); 4-14
Клиническая фармация; Том 24 № 4 (2020); 4-14
Клінічна фармація; Том 24 № 4 (2020); 4-14
Клінічна фармація; Том 24, № 4 (2020); 4-14
Clinical pharmacy; Том 24, № 4 (2020); 4-14
Клиническая фармация; Том 24, № 4 (2020); 4-14
For many years, acute respiratory viral infections and influenza have remained a serious medical and social health problem as a leading cause of missing days at work by adults and schools or kindergartens by children, increased costs of medical care
Publikováno v:
Clinical pharmacy; Vol. 24 No. 3 (2020); 04-16
Клиническая фармация; Том 24 № 3 (2020); 04-16
Клінічна фармація; Том 24 № 3 (2020); 04-16
Клиническая фармация; Том 24 № 3 (2020); 04-16
Клінічна фармація; Том 24 № 3 (2020); 04-16
Despite the success achieved in the prevention and treatment of acute respiratory viral infections their annual prevalence exceeds the prevalence of the rest of the infectious diseases, and their portion in the overall structure of the infectious dis
Publikováno v:
Клінічна фармація; Том 24, № 2 (2020); 9-17
Clinical pharmacy; Том 24, № 2 (2020); 9-17
Клиническая фармация; Том 24, № 2 (2020); 9-17
Clinical pharmacy; Vol. 24 No. 2 (2020); 9-17
Клиническая фармация; Том 24 № 2 (2020); 9-17
Клінічна фармація; Том 24 № 2 (2020); 9-17
Clinical pharmacy; Том 24, № 2 (2020); 9-17
Клиническая фармация; Том 24, № 2 (2020); 9-17
Clinical pharmacy; Vol. 24 No. 2 (2020); 9-17
Клиническая фармация; Том 24 № 2 (2020); 9-17
Клінічна фармація; Том 24 № 2 (2020); 9-17
The choice of an optimal drug is only one of the components of high-quality pharmacotherapy of acute rhinosinusitis, which is supplemented by providing a patient with full information about the action of the drug selected, its rational use and durati
Publikováno v:
Патологія; № 1 (2020)
Pathologia; № 1 (2020)
Патология; № 1 (2020)
Pathologia; № 1 (2020)
Патология; № 1 (2020)
In the absence of effective and safety therapy for COVID-19 patients, today the search for new methods of treatment is the most actual topic in medicine and pharmacy. High mortality (7.1 %) due to the development of acute respiratory distress-syndrom
Publikováno v:
Current issues in pharmacy and medicine: science and practice; Vol. 13 No. 1 (2020)
Актуальные вопросы фармацевтической и медицинской науки и практики; Том 13 № 1 (2020)
Актуальні питання фармацевтичної та медичної науки та практики; Том 13 № 1 (2020)
Актуальные вопросы фармацевтической и медицинской науки и практики; Том 13 № 1 (2020)
Актуальні питання фармацевтичної та медичної науки та практики; Том 13 № 1 (2020)
Recently, there has been a trend towards wider use of herbal medicines, which is associated with their pharmacodynamic polytropy, a fairly high level of safety and economic affordability.The aim of the work is the study chondroprotective properties o
Publikováno v:
Клінічна фармація; Том 24, № 1 (2020); 56-62
Clinical pharmacy; Том 24, № 1 (2020); 56-62
Клиническая фармация; Том 24, № 1 (2020); 56-62
Clinical pharmacy; Vol. 24 No. 1 (2020); 56-62
Клиническая фармация; Том 24 № 1 (2020); 56-62
Клінічна фармація; Том 24 № 1 (2020); 56-62
Clinical pharmacy; Том 24, № 1 (2020); 56-62
Клиническая фармация; Том 24, № 1 (2020); 56-62
Clinical pharmacy; Vol. 24 No. 1 (2020); 56-62
Клиническая фармация; Том 24 № 1 (2020); 56-62
Клінічна фармація; Том 24 № 1 (2020); 56-62
Nowadays, one of the most topical issues in the healthcare system ofUkraineis to ensure the quality of laboratory research. For this purpose, it is necessary to develop and implement a quality system in accordance with ISO 15189: 2015 “Medical labo
Publikováno v:
Клінічна фармація; Том 24, № 1 (2020); 36-45
Clinical pharmacy; Том 24, № 1 (2020); 36-45
Клиническая фармация; Том 24, № 1 (2020); 36-45
Clinical pharmacy; Vol. 24 No. 1 (2020); 36-45
Клиническая фармация; Том 24 № 1 (2020); 36-45
Клінічна фармація; Том 24 № 1 (2020); 36-45
Clinical pharmacy; Том 24, № 1 (2020); 36-45
Клиническая фармация; Том 24, № 1 (2020); 36-45
Clinical pharmacy; Vol. 24 No. 1 (2020); 36-45
Клиническая фармация; Том 24 № 1 (2020); 36-45
Клінічна фармація; Том 24 № 1 (2020); 36-45
According to the WHO the pathology of the urinary system affects the population of different ages and averages 10 % of the total population in the world. Today, in the domestic healthcare system there are about 500 thousand patients with chronic kidn
Publikováno v:
Український біофармацевтичний журнал; № 1(62) (2020); 43-49
Ukrainian biopharmaceutical journal; № 1(62) (2020); 43-49
Украинский биофармацевтический журнал; № 1(62) (2020); 43-49
Ukrainian biopharmaceutical journal; № 1(62) (2020); 43-49
Украинский биофармацевтический журнал; № 1(62) (2020); 43-49
Topicality. Over the past decades, traditional medicines, in particular herbal preparations, have become increasingly widespread worldwide, due to their multivector pharmacodynamics, a high enough level of safety and accessibility to a wide populatio
Publikováno v:
Clinical pharmacy; Vol. 23 No. 3 (2019); 12-18
Клиническая фармация; Том 23 № 3 (2019); 12-18
Клінічна фармація; Том 23 № 3 (2019); 12-18
Клиническая фармация; Том 23 № 3 (2019); 12-18
Клінічна фармація; Том 23 № 3 (2019); 12-18
A modern clinical and diagnostic laboratory should solve the problems of implementing and maintaining the quality system based on the application of the principles of the specialized standard ISO 15189: 2015 “Medical laboratories. Some requirements
Publikováno v:
Clinical pharmacy; Vol. 22 No. 4 (2018); 12-18
Клиническая фармация; Том 22 № 4 (2018); 12-18
Клінічна фармація; Том 22 № 4 (2018); 12-18
Клиническая фармация; Том 22 № 4 (2018); 12-18
Клінічна фармація; Том 22 № 4 (2018); 12-18
The importance of dyslipidemia as one of the main risk factors of cardiovascular disease is currently undoubted. Medicines of plant origin with the anti-atherogenic potential are of particular relevance for prevention of the dyslipidemia development